Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DESIGN study of sodium intake and ertugliflozin effects in type 2 diabetes
NL-OMON60510Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ertugliflozin, sponsored by Amsterdam University Medical Center. Started Jul 2023; status: completed.
02
Drugs
ertugliflozin
Beyond the preview
Go deeper on NL-OMON60510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60510.